Erratum: Tiam1 is associated with hepatocellular carcinoma metastasis (International Journal of Cancer (2013) 132: 1 (90-100) DOI: 10.1002/ijc.27627);Tiam1 is associated with hepatocellular carcinoma metastasis

International Journal of Cancer

Volumn 132, Issue 1, 2013, Pages 90-100

  Huang, Jing ^a   Ye, Xianghua ^a   Guan, Jian ^a   Chen, Bin ^b   Li, Qisheng ^a   Zheng, Xiaokang ^a   Liu, Laiyu ^a   Wang, Shuang ^a   Ding, Yanqing ^a   Ding, Yi ^a   Chen, Longhua ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

biomarker; hepatocellular carcinoma; invasion; metastasis; Tiam1 gene

Indexed keywords

EID: 84868210883     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29622     Document Type: Erratum

References (31)

1. Feng YX, Zhao JS, Li JJ, et al. Liver cancer: ephrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway 120. Hepatology 2010; 51: 535-44.
2. Zheng K, Li HY, Su XL, et al. Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells. J Exp Clin Cancer Res 2010; 29: 31.
3. Lau SH, Sham JS, Xie D, et al. Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene 2006; 25: 1242-50.
4. Chen L, Chan TH, Yuan YF, et al. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J Clin Invest 2010; 120: 1178-91.
5. Habets GG, Scholtes EH, Zuydgeest D, et al. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 1994; 77: 537-49.
6. Michiels F, Habets GG, Stam JC, et al. A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature 1995; 375: 338-40.
7. Minard ME, Kim LS, Price JE, et al. The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat 2004; 84: 21-32.
8. Liu H, Shi G, Liu X, et al. Overexpression of Tiam1 predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncol Rep 2011; 25: 841-8.
9. Stebel A, Brachetti C, Kunkel M, et al. Progression of breast tumors is accompanied by a decrease in expression of the Rho guanine exchange factor Tiam1. Oncol Rep 2009; 21: 217-22.
10. Adam L, Vadlamudi RK, McCrea P, et al. Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta -catenin nuclear signaling in breast cancer cells by modulating the intercellular stability. J Biol Chem 2001; 276: 28443-50.
11. Jin H, Li T, Ding Y, et al. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer. Hum Pathol 2011; 42: 541-51.
12. Liu L, Wu DH, Ding YQ,. Tiam1 gene expression and its significance in colorectal carcinoma. World J Gastroenterol 2005; 11: 705-7.
13. Engers R, Mueller M, Walter A, et al. Prognostic relevance of Tiam1 protein expression in prostate carcinomas. Br J Cancer 2006; 95: 1081-6.
14. Hou M, Tan L, Wang X, et al. Antisense Tiam1 down-regulates the invasiveness of 95D cells in vitro. Acta Biochim Biophys Sin (Shanghai) 2004; 36: 537-40.
15. Malliri A, van der Kammen RA, Clark K, et al. Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 2002; 417: 867-71.
16. Zhao L, Liu Y, Sun X, et al. Overexpression of T lymphoma invasion and metastasis 1 predict renal cell carcinoma metastasis and overall patient survival. J Cancer Res Clin Oncol 2011; 137: 393-8.
17. Ding Y, Chen B, Wang S, et al. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients. Int J Cancer 2009; 124: 653-8.
18. Li Y, Tian B, Yang J, et al. Stepwise metastatic human hepatocellular carcinoma cell model system with multpiple metastatic established through consecutive in vivo selection and studies on metastatic characteristics. J Cance Res Clin Oncol 2004, 130: 460-8.
19. van Leeuwen FN, van der Kammen RA, Habets GG, et al. Oncogenic activity of Tiam1 and Rac1 in NIH3T3 cells. Oncogene 1995; 11: 2215-21.
20. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) Method. Methods 2001; 25: 402-8.
21. Uchino K, Tateishi R, Shiina S, et al. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer 2011; 117: 4475-83.
22. Liu L, Zhang Q, Zhang Y, et al. Lentivirus-mediated silencing of Tiam1 gene influences multiple functions of a human colorectal cancer cell line. Neoplasia 2006; 8: 917-24.
23. Minard ME, Ellis LM, Gallick GE,. Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clin Exp Metastasis 2006; 23: 301-3.
24. Zhang XM, Ding Y, Chen JZ, et al. Overexpression of Tiam1 gene and its relationship with invasive and metastatic ability of nasopharyngeal carcinoma. Zhonghua Bing Li Xue Za Zhi 2009; 38: 268-72.
25. Leeuwen FN, Kain HE, Kammen RA, et al. The guanine nucleotide exchange factor Tiam1 affects neuronal morphology; opposing roles for the small GTPases Rac and Rho. J Cell Biol 1997; 139: 797-807.
26. Xu K, Rajagopal S, Klebba I, et al. The role of fibroblast Tiam1 in tumor cell invasion and metastasis. Oncogene 2010; 29: 6533-42.
27. Hordijk PL, ten Klooster JP, van der Kammen RA, et al. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 1997; 278: 1464-6.
28. Engers R, Zwaka TP, Gohr L, et al. Tiam1 mutations in human renal-cell carcinomas. Int J Cancer 2000; 88: 369-76.
29. Xu Y, Sun HC, Tian B, et al. Establishment of green fluorescent protein-expressing hepatocellular carcinoma cell lines with different metastatic potential: relevant models for in vivo monitoring of metastasis and angiogenesis. J Cancer Res Clin Oncol 2004; 130: 375-82.
30. Stefanska B, Huang J, Bhattacharyya B, et al. Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res 2011; 71: 5891-903.
31. Kong LM, Liao CG, Chen L, et al. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma. J Cell Mol Med 2011; 15: 1415-28.